Amanote Research

Amanote Research

    RegisterSign In

Treatment and Survival Vary by Race/Ethnicity in Patients With Anaplastic Thyroid Cancer

Cancer - United States
doi 10.1002/cncr.31252
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

February 6, 2018

Authors
Ansley M. RocheStacey A. FedewaLucy L. ShiAmy Y. Chen
Publisher

Wiley


Related search

Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Delay in Surgical Treatment and Survival After Breast Cancer Diagnosis in Young Women by Race/Ethnicity

JAMA Surgery
Surgery
2013English

Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types

JAMA network open
Medicine
2020English

Insurance Status and Cancer Treatment Mediate the Association Between Race/Ethnicity and Cervical Cancer Survival

PLoS ONE
Multidisciplinary
2018English

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Minimally Invasive Thyroid Anaplastic Carcinoma With Long Survival

Turkish Journal of Surgery
2018English

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival

Case Reports in Oncological Medicine
Oncology
2013English

Cervical Cancer Survival by Socioeconomic Status, Race/Ethnicity, and Place of Residence in Texas, 1995–2001

Journal of Women's Health
Medicine
2006English

Do Judges Vary in Their Treatment of Race?

Journal of Legal Studies
Law
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy